Tune Therapeutics is a biotechnology company specializing in epigenome editing to develop cell and gene therapies aimed at treating severe diseases. The company is committed to advancing the science of epigenetic programming, which has the potential to profoundly change patient care. Tune Therapeutics is building a diverse and skilled team of professionals experienced in drug discovery, development, and commercialization. The organization values collaboration, scientific rigor, and innovative thinking, and it fosters a supportive environment that encourages the exploration of new ideas and technologies. By focusing on transformative therapies, Tune Therapeutics aims to make significant contributions to healthcare and improve the lives of patients affected by debilitating conditions.